MARKET

PTHS

PTHS

Pelthos Therapeutics
AMEX
25.77
-2.23
-7.96%
After Hours: 25.77 0 0.00% 16:04 07/02 EDT
OPEN
27.63
PREV CLOSE
28.00
HIGH
27.75
LOW
25.40
VOLUME
27.66K
TURNOVER
--
52 WEEK HIGH
54.29
52 WEEK LOW
12.30
MARKET CAP
89.57M
P/E (TTM)
-1.2514
1D
5D
1M
3M
1Y
5Y
1D
Pelthos Therapeutics Joins The Russell 3000E Growth Benchmark, Russell Microcap And Russell Microcap Growth Benchmark Indexes
Benzinga · 3d ago
Analysts Offer Insights on Healthcare Companies: Pelthos Therapeutics (PTHS) and Lantheus (LNTH)
TipRanks · 4d ago
Weekly Report: what happened at PTHS last week (0622-0626)?
Weekly Report · 4d ago
Analysts Offer Insights on Healthcare Companies: Pelthos Therapeutics (PTHS), Neumora Therapeutics, Inc. (NMRA) and Amgen (AMGN)
TipRanks · 06/22 12:23
Weekly Report: what happened at PTHS last week (0615-0619)?
Weekly Report · 06/22 10:33
Tuesday 6/16 Insider Buying Report: LODE, PTHS
NASDAQ · 06/16 20:20
Insider Makes Bold Move With Major Pelthos Therapeutics Stock Buy
TipRanks · 06/16 02:06
Alliance Global Partners Remains a Buy on Pelthos Therapeutics (PTHS)
TipRanks · 06/15 11:37
More
About PTHS
Pelthos Therapeutics Inc. is a biopharmaceutical company focused on commercializing therapeutic products for unmet patient needs. The Company's lead product, ZELSUVMI (berdazimer) topical gel, 10.3%, is used in the treatment of molluscum contagiosum infections (molluscum) in adults and pediatric patients one year of age and older. In addition to ZELSUVMI, the Company has a pipeline of product candidates that utilize its proprietary nitric oxide-based technology platform, NITRICIL. The Company’s product Xepi is a quinolone antimicrobial indicated for the topical treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients two months of age and older. Its NaV 1.7 is a clinical-stage assets which selectively target the sodium ion-channel. The Company also Xeglyze, which is a is a pediculicide indicated for the topical treatment of head lice infestation in patients six months of age and older.

Webull offers Pelthos Therapeutics Inc stock information, including AMEX: PTHS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PTHS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PTHS stock methods without spending real money on the virtual paper trading platform.